Explore MyBioSource's premium PCR kits for disease detection and genetic research, offering fast, accurate results for oncology, infectious diseases, and more.

Market expert Raja Venkatraman shares his top stocks to buy today, 14 January. Discover his exclusive picks and analysis to ...

Indore: Amid the ongoing water contamination crisis in Bhagirathpura locality, which has claimed multiple lives and affected ...

Co-Diagnostics receives Australian patent covering Co-Dx PCR platform technologies for nucleic acid detection and analysis: Salt Lake City Wednesday, December 31, 2025, 11:00 Hrs ...

PCR-based techniques have transformed how scientists analyze transcripts’ translational applications in cancer and ...

Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented ...

DNA analysis is a crucial tool for identifying harmful pathogens, such as bacteria, viruses, or fungi, that cause infections.

The Australian patent represents the first patent granted for the Company's new point-of-care testing platform ...

AIV prevalence is monitored in hunter-killed waterfowl in the Sacramento Valley of California. Overall virus prevalence in ...

Building on strong momentum in 2025, new product launches and regulatory milestones planned for 2026 to support goal of at ...

CoDiagnostics secures its first patent for the Co-Dx PCR platform in Australia, strengthening IP protection as the point-of-care system awaits regulatory clearance.

The Budh Vihar Police Station on Monday received a PCR call at 11:49 pm regarding an accident involving a scooty and an i20 ...